ADAM17 and pancreatic adenocarcinoma: Our previous study indicated that hypomethylation of ADAM17 in PAAD tumor tissues was positively correlated with high ADAM17 expression, indicating that hypomethylation of the ADAM17 promoter may be responsible for its increased expression in PAAD tissues.